Messenger RNA

Circular RNA

Cancer stem cell

Immunoprecipitation

Biology

Promoter

Gene

Cancer

Gene expression

Chromatin immunoprecipitation

Wnt signaling pathway

microRNA

Metastasis

Stem cell

RNA-binding protein

RNA splicing

Signal transduction

Cell biology

Cancer research

Genetics

Theranostics

Circular RNA (circRNA) possesses great pre-clinical diagnostic and therapeutic potentials in multiple cancers.It has been reported playing roles in multiple malignant behaviors including proliferation, migration, metastasis and chemoresistance.However, the underlying correlation between circRNAs and cancer stem cells (CSCs) has not been reported yet.Methods: circZKSCAN1 level was detected in HCC tissue microarrays to clarify its prognostic values.Gain and loss function experiments were applied to investigate the role of circZKSCAN1 in HCC stemness.Bioinformatic analysis was used to predict the possible downstream RNA binding protein and further RNA immunoprecipitation sequencing was carried out to identify the RBP-regulated genes. Results:The absence of circZKSCAN1 endowed several malignant properties including cancer stemness and tightly correlated with worse overall and recurrence-free survival rate in HCC.Bioinformatics analysis and RNA immunoprecipitation-sequencing (RIP-seq) results revealed that circZKSCAN1 exerted its inhibitive role by competitively binding FMRP, therefore, block the binding between FMRP and β-catenin-binding protein-cell cycle and apoptosis regulator 1 (CCAR1) mRNA, and subsequently restrain the transcriptional activity of Wnt signaling.In addition, RNA-splicing protein Quaking 5 was found downregulated in HCC tissues and responsible for the reduction of circZKSCAN1. Conclusion:Collectively, this study revealed the mechanisms underlying the regulatory role of circZKSCAN1 in HCC CSCs and identified the newly discovered Qki5-circZKSCAN1-FMRP-CCAR1-Wnt signaling axis as a potentially important therapeutic target for HCC treatment.

Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma